TGT Total Current Liabilities

Target Corporation · Total Current Liabilities

TGT logo

TGT Total Current Liabilities

Latest reported$21.18B
TGT Quarterly Current Liabilities ($1.42B → $21.18B)
High-resolution chart · PNG

TGT total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Target Corporation Total Current Liabilities — Quarterly (USD)
Period endingTotal Current Liabilities (USD)
21,180,000,000
19,384,000,000
21,230,000,000
21,242,000,000
19,223,000,000
18,991,000,000
20,799,000,000
21,792,000,000
19,984,000,000
19,859,000,000
19,304,000,000
21,502,000,000
19,332,000,000
17,867,000,000
19,500,000,000
23,783,000,000
22,445,000,000
20,724,000,000
21,747,000,000
23,351,000,000
19,422,000,000
18,598,000,000
20,125,000,000
19,357,000,000
15,892,000,000
14,412,000,000
14,487,000,000
16,608,000,000
14,364,000,000
13,239,000,000
15,014,000,000
17,590,000,000
14,038,000,000
12,044,000,000
13,052,000,000
15,376,000,000
12,729,000,000
12,392,000,000
12,708,000,000
12,642,000,000
11,003,000,000
12,019,000,000
12,622,000,000
13,858,000,000
11,613,000,000
10,648,000,000
11,736,000,000
13,525,000,000
11,336,000,000
12,040,000,000
12,777,000,000
14,551,000,000
12,616,000,000
11,159,000,000
14,031,000,000
15,709,000,000
13,329,000,000
12,446,000,000
14,287,000,000
14,139,000,000
11,620,000,000
10,838,000,000
10,070,000,000
11,790,000,000
10,100,000,000
10,197,000,000
11,327,000,000
12,398,000,000
9,810,000,000
10,249,000,000
10,512,000,000
13,496,000,000
11,359,000,000
10,959,000,000
11,782,000,000
13,563,000,000
11,022,000,000
10,097,000,000
11,117,000,000
11,921,000,000
9,660,000,000
9,708,000,000
9,588,000,000
9,641,000,000
8,037,000,000
7,173,000,000
8,220,000,000
8,485,000,000
7,952,000,000
8,235,000,000
8,314,000,000
8,596,000,000
6,961,000,000
6,801,000,000
7,523,000,000
8,137,000,000
7,801,000,000
6,851,000,000
7,054,000,000
6,938,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.